Using an interventional approach, we assessed the effects of pharmacological inhibition of HDAC6 by administration of the specific inhibitor TS in an experimental model of Type 1 diabetes (STZ-rats). This evidence concerns the gene HDAC6 and type 1 diabetes mellitus.